195 related articles for article (PubMed ID: 17898350)
1. Association of the tau haplotype H2 with age at onset and functional alterations of glucose utilization in frontotemporal dementia.
Laws SM; Perneczky R; Drzezga A; Diehl-Schmid J; Ibach B; Bäuml J; Eisele T; Förstl H; Kurz A; Riemenschneider M
Am J Psychiatry; 2007 Oct; 164(10):1577-84. PubMed ID: 17898350
[TBL] [Abstract][Full Text] [Related]
2. The H2 MAPT haplotype is associated with familial frontotemporal dementia.
Ghidoni R; Signorini S; Barbiero L; Sina E; Cominelli P; Villa A; Benussi L; Binetti G
Neurobiol Dis; 2006 May; 22(2):357-62. PubMed ID: 16410051
[TBL] [Abstract][Full Text] [Related]
3. Genetic analysis of MAPT haplotype diversity in frontotemporal dementia.
Laws SM; Friedrich P; Diehl-Schmid J; Müller J; Ibach B; Bäuml J; Eisele T; Förstl H; Kurz A; Riemenschneider M
Neurobiol Aging; 2008 Aug; 29(8):1276-8. PubMed ID: 17386961
[TBL] [Abstract][Full Text] [Related]
4. Association between tau H2 haplotype and age at onset in frontotemporal dementia.
Borroni B; Yancopoulou D; Tsutsui M; Padovani A; Sawcer SJ; Hodges JR; Spillantini MG
Arch Neurol; 2005 Sep; 62(9):1419-22. PubMed ID: 16157749
[TBL] [Abstract][Full Text] [Related]
5. H1 haplotype of the MAPT gene is associated with lower regional gray matter volume in healthy carriers.
Canu E; Boccardi M; Ghidoni R; Benussi L; Testa C; Pievani M; Bonetti M; Binetti G; Frisoni GB
Eur J Hum Genet; 2009 Mar; 17(3):287-94. PubMed ID: 18854867
[TBL] [Abstract][Full Text] [Related]
6. MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study.
Valentino RR; Scotton WJ; Roemer SF; Lashley T; Heckman MG; Shoai M; Martinez-Carrasco A; Tamvaka N; Walton RL; Baker MC; Macpherson HL; Real R; Soto-Beasley AI; Mok K; Revesz T; Christopher EA; DeTure M; Seeley WW; Lee EB; Frosch MP; Molina-Porcel L; Gefen T; Redding-Ochoa J; Ghetti B; Robinson AC; Kobylecki C; Rowe JB; Beach TG; Teich AF; Keith JL; Bodi I; Halliday GM; Gearing M; Arzberger T; Morris CM; White CL; Mechawar N; Boluda S; MacKenzie IR; McLean C; Cykowski MD; Wang SJ; Graff C; Nagra RM; Kovacs GG; Giaccone G; Neumann M; Ang LC; Carvalho A; Morris HR; Rademakers R; Hardy JA; Dickson DW; Rohrer JD; Ross OA;
Lancet Neurol; 2024 May; 23(5):487-499. PubMed ID: 38631765
[TBL] [Abstract][Full Text] [Related]
7. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
[TBL] [Abstract][Full Text] [Related]
8. Association between the extended tau haplotype and frontotemporal dementia.
Verpillat P; Camuzat A; Hannequin D; Thomas-Anterion C; Puel M; Belliard S; Dubois B; Didic M; Michel BF; Lacomblez L; Moreaud O; Sellal F; Golfier V; Campion D; Clerget-Darpoux F; Brice A
Arch Neurol; 2002 Jun; 59(6):935-9. PubMed ID: 12056929
[TBL] [Abstract][Full Text] [Related]
9. MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.
Pastor P; Moreno F; Clarimón J; Ruiz A; Combarros O; Calero M; López de Munain A; Bullido MJ; de Pancorbo MM; Carro E; Antonell A; Coto E; Ortega-Cubero S; Hernandez I; Tárraga L; Boada M; Lleó A; Dols-Icardo O; Kulisevsky J; Vázquez-Higuera JL; Infante J; Rábano A; Fernández-Blázquez MÁ; Valentí M; Indakoetxea B; Barandiarán M; Gorostidi A; Frank-García A; Sastre I; Lorenzo E; Pastor MA; Elcoroaristizabal X; Lennarz M; Maier W; Rámirez A; Serrano-Ríos M; Lee SE; Sánchez-Juan P;
J Alzheimers Dis; 2016; 49(2):343-52. PubMed ID: 26444794
[TBL] [Abstract][Full Text] [Related]
10. Novel tau polymorphisms, tau haplotypes, and splicing in familial and sporadic frontotemporal dementia.
Sobrido MJ; Miller BL; Havlioglu N; Zhukareva V; Jiang Z; Nasreddine ZS; Lee VM; Chow TW; Wilhelmsen KC; Cummings JL; Wu JY; Geschwind DH
Arch Neurol; 2003 May; 60(5):698-702. PubMed ID: 12756133
[TBL] [Abstract][Full Text] [Related]
11. Brain hypometabolism in non-demented microtubule-associated protein tau H1 carriers with Parkinson's disease.
Gasca-Salas C; Trompeta C; López-Aguirre M; Rodríguez Rojas R; Clarimon J; Dols-Icardo O; El Bounasri S; Guida P; Mata-Marín D; Hernández-Fernández F; Marras C; García-Cañamaque L; Plaza de Las Heras I; Obeso I; Vela L; Fernández-Rodríguez B
J Neuroimaging; 2023; 33(6):953-959. PubMed ID: 37726927
[TBL] [Abstract][Full Text] [Related]
12. Tau PET Imaging with [18F]PM-PBB3 in Frontotemporal Dementia with MAPT Mutation.
Su Y; Fu J; Yu J; Zhao Q; Guan Y; Zuo C; Li M; Tan H; Cheng X
J Alzheimers Dis; 2020; 76(1):149-157. PubMed ID: 32444551
[TBL] [Abstract][Full Text] [Related]
13. Pattern of glucose hypometabolism in frontotemporal dementia with motor neuron disease.
Jeong Y; Park KC; Cho SS; Kim EJ; Kang SJ; Kim SE; Kang E; Na DL
Neurology; 2005 Feb; 64(4):734-6. PubMed ID: 15728305
[TBL] [Abstract][Full Text] [Related]
14. Mutation screening of the MAPT and STH genes in Polish patients with clinically diagnosed frontotemporal dementia.
Zekanowski C; Pepłońska B; Styczyńska M; Gustaw K; Kuźnicki J; Barcikowska M
Dement Geriatr Cogn Disord; 2003; 16(3):126-31. PubMed ID: 12826737
[TBL] [Abstract][Full Text] [Related]
15. MAPT subhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features.
Valentino RR; Koga S; Walton RL; Soto-Beasley AI; Kouri N; DeTure MA; Murray ME; Johnson PW; Petersen RC; Boeve BF; Uitti RJ; Wszolek ZK; Dickson DW; Ross OA; Heckman MG
Acta Neuropathol Commun; 2020 Dec; 8(1):218. PubMed ID: 33287913
[TBL] [Abstract][Full Text] [Related]
16. Haplotype-specific expression of exon 10 at the human MAPT locus.
Caffrey TM; Joachim C; Paracchini S; Esiri MM; Wade-Martins R
Hum Mol Genet; 2006 Dec; 15(24):3529-37. PubMed ID: 17085483
[TBL] [Abstract][Full Text] [Related]
17. Structural study of the microtubule-associated protein tau locus of Alzheimer's disease in Taiwan.
Chang CW; Hsu WC; Pittman A; Wu YR; Hardy J; Fung HC
Biomed J; 2014; 37(3):127-32. PubMed ID: 24923570
[TBL] [Abstract][Full Text] [Related]
18. Role of MAPT mutations and haplotype in frontotemporal lobar degeneration in Northern Finland.
Kaivorinne AL; Krüger J; Kuivaniemi K; Tuominen H; Moilanen V; Majamaa K; Remes AM
BMC Neurol; 2008 Dec; 8():48. PubMed ID: 19091059
[TBL] [Abstract][Full Text] [Related]
19. The MAPT H1 haplotype is associated with tangle-predominant dementia.
Santa-Maria I; Haggiagi A; Liu X; Wasserscheid J; Nelson PT; Dewar K; Clark LN; Crary JF
Acta Neuropathol; 2012 Nov; 124(5):693-704. PubMed ID: 22802095
[TBL] [Abstract][Full Text] [Related]
20. Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study.
Diehl J; Grimmer T; Drzezga A; Riemenschneider M; Förstl H; Kurz A
Neurobiol Aging; 2004 Sep; 25(8):1051-6. PubMed ID: 15212830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
